Post-transplant relapse

Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care

Volumn , Issue , 2011, Pages 271-276

  Maziarz, Richard T ^a   Slater, Susan ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892267596     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-7506-5_24     Document Type: Chapter

References (8)

1. Bishop, R., Alyea, E., Cairo, M., Falkenburg, J., June, C., Kroger, N., et al. (2010). Introduction to the reports from the National Cancer Institute First International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 16:563-564.
2. Burzynski, J., Toro, J., Patel, R., Lee, S., Greene, R., Ochoa-Bayona, J., et al. (2009). Toxicity of a second autologous peripheral blood stem cell transplant in patients with relapsed or recurrent multiple myeloma. Leuk Lymphoma, 50:1442-1447.
3. Cairo, M., Jordan, C., Maley, C., Chao, C., Melnick, A., Armstrong, S., et al. (2010). NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: Report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: State of the science. Biol Blood Marrow Tranplant, 16:709-728.
4. Devetten, M., Hari, P., Carreras, J., Logan, B., Van Besien, K., Bredeson, C., et al. (2009). Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relasped and refractory Hodgkin lymphoma. Biol Blood Marrow Transplant, 15:109-117.
5. Freytes, C., Lazarus, H. (2009). Second hematopoietic SCT for lymphoma patients who relapse after autotransplantation: Another autograft or switch to allograft? Bone Marrow Transplant, 44:559-569.
6. Kroger, N., Bacher, U., Bader, P., Bottcher, S., Borowitz, M. J., Dreger, P., et al. (2010). NCI first international workshop on the biology, prevention and treatment of relapse after allogeneic hematopoietic stem cell transplantation: Report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. Part I: Methods, acute leukemias and myelodyspastic syndromes. Biol Blood Marrow Transplant, 16:1325-1346.
7. Miller, J., Warren, E., Van Den Brink, M., Ritz, J., Shlomchik, W., Murphy, W., et al. (2010). NCI first international workshop on the biology, prevention and treatment of relapse after allogeneic hematopoietic stem cell transplantation: Report from the committee on the biology underlying recurrence of malignant disease following allogeneic HSCT: Graft-versus-tumor/leukemia reaction. Biol Blood Marrow Transplant, 16:565-586.
8. Olin, R., Vogl, D., Porter, D., Luger, S., Schuster, S., Tsai, D., et al. (2009). Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma. Bone Marrow Transplant, 43:417-422.